PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,844 | -73.3% | 46 | -72.8% | 0.00% | -100.0% |
| Q1 2023 | $6,897 | +54.0% | 169 | +45.7% | 0.00% | +100.0% |
| Q4 2022 | $4,479 | -10.4% | 116 | +17.2% | 0.00% | -50.0% |
| Q3 2022 | $5,000 | -37.5% | 99 | -26.7% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | 0.0% | 135 | +25.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -11.1% | 108 | -28.5% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | +28.6% | 151 | +24.8% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | 0.0% | 121 | +3.4% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | -22.2% | 117 | -7.9% | 0.00% | -33.3% |
| Q1 2021 | $9,000 | +12.5% | 127 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +300.0% | 127 | +273.5% | 0.00% | +200.0% |
| Q3 2020 | $2,000 | +100.0% | 34 | +21.4% | 0.00% | – |
| Q2 2020 | $1,000 | – | 28 | +180.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 10 | -79.6% | 0.00% | -100.0% |
| Q4 2019 | $2,000 | -66.7% | 49 | -59.8% | 0.00% | -66.7% |
| Q1 2016 | $6,000 | – | 122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |